Literature DB >> 18054696

Infantile botulism caused by Clostridium butyricum type E toxin.

Yuichi Abe1, Tetsuro Negasawa, Chie Monma, Akira Oka.   

Abstract

The case of a 9-month-old boy with infantile botulism caused by Clostridium butyricum type E toxin is reported. Because infantile botulism is rare in Japan, it was difficult to diagnose it at an early stage. Electrophysiologic findings were useful for the diagnosis, and were characterized by incremental responses (waxing) to short intervals and rapid repetitive nerve stimulation. A bioassay for botulism in mice indicated that the patient had botulism due to type E or F botulinum toxin. C. butyricum type E was isolated from his feces, confirming the diagnosis. This is the first known case of infantile botulism due to C. butyricum type E toxin in Japan.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18054696     DOI: 10.1016/j.pediatrneurol.2007.08.013

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  11 in total

1.  Laboratory Investigation of the First Case of Botulism Caused by Clostridium butyricum Type E Toxin in the United States.

Authors:  Janet K Dykes; Carolina Lúquez; Brian H Raphael; Loretta McCroskey; Susan E Maslanka
Journal:  J Clin Microbiol       Date:  2015-08-05       Impact factor: 5.948

2.  Multiplex PCR for detection of botulinum neurotoxin-producing clostridia in clinical, food, and environmental samples.

Authors:  Dario De Medici; Fabrizio Anniballi; Gary M Wyatt; Miia Lindström; Ute Messelhäusser; Clare F Aldus; Elisabetta Delibato; Hannu Korkeala; Michael W Peck; Lucia Fenicia
Journal:  Appl Environ Microbiol       Date:  2009-08-14       Impact factor: 4.792

3.  Equine botulinum antitoxin for the treatment of infant botulism.

Authors:  Elida E Vanella de Cuetos; Rafael A Fernandez; María I Bianco; Omar J Sartori; María L Piovano; Carolina Lúquez; Laura I T de Jong
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

4.  First report worldwide of an infant botulism case due to Clostridium botulinum type E.

Authors:  Carolina Lúquez; Janet K Dykes; Patricia A Yu; Brian H Raphael; Susan E Maslanka
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

5.  Identification of novel linear megaplasmids carrying a ß-lactamase gene in neurotoxigenic Clostridium butyricum type E strains.

Authors:  Giovanna Franciosa; Concetta Scalfaro; Paola Di Bonito; Marco Vitale; Paolo Aureli
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

6.  Infant botulism due to C. butyricum type E toxin: a novel environmental association with pet terrapins.

Authors:  E B Shelley; D O'Rourke; K Grant; E McArdle; L Capra; A Clarke; E McNamara; R Cunney; P McKeown; C F L Amar; C Cosgrove; M Fitzgerald; P Harrington; P Garvey; F Grainger; J Griffin; B J Lynch; G McGrane; J Murphy; N Ni Shuibhne; J Prosser
Journal:  Epidemiol Infect       Date:  2014-10-13       Impact factor: 4.434

7.  Effects of Megaplasmid Loss on Growth of Neurotoxigenic Clostridium butyricum Strains and Botulinum Neurotoxin Type E Expression.

Authors:  Concetta Scalfaro; Angelo Iacobino; Laura Grande; Stefano Morabito; Giovanna Franciosa
Journal:  Front Microbiol       Date:  2016-02-25       Impact factor: 5.640

8.  Type E Botulinum Neurotoxin-Producing Clostridium butyricum Strains Are Aerotolerant during Vegetative Growth.

Authors:  Serena Camerini; Lucia Marcocci; Lara Picarazzi; Egidio Iorio; Irene Ruspantini; Paola Pietrangeli; Marco Crescenzi; Giovanna Franciosa
Journal:  mSystems       Date:  2019-04-30       Impact factor: 6.496

Review 9.  Public Health Risk Associated with Botulism as Foodborne Zoonoses.

Authors:  Christine Rasetti-Escargueil; Emmanuel Lemichez; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2019-12-30       Impact factor: 4.546

Review 10.  Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases.

Authors:  Haokun Shen; Zitong Zhao; Zengjue Zhao; Yuyi Chen; Linghua Zhang
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.